Jh. Proost, ADAPTIVE-CONTROL OF DRUG-DOSAGE REGIMENS USING MAXIMUM A-POSTERIORI PROBABILITY BAYESIAN FITTING, International journal of clinical pharmacology and therapeutics, 33(10), 1995, pp. 531-536
Optimal drug therapy can only be achieved if a drug is given in the ri
ght dosage regimen. Therefore the dosage regimen needs to be optimized
, using the available information of the drug, the patient, and his di
sease. The optimization of drug therapy comprises two major steps: Fir
st, the clinician should define explicit therapeutic goals for each pa
tient individually. Second, a strategy to achieve these goals with the
greatest possible precision should be chosen. An overview of the opti
mization of drug therapy is presented, with special reference to maxim
um a posteriori probability (MAP) Bayesian fitting. Drug dosage optimi
zation requires 1. measurement of a performance index related to the t
herapeutic goal, generally one or more plasma concentration measuremen
ts, 2. population pharmacokinetic parameters, including mean values, s
tandard deviations, covariances and information on the statistical dis
tribution, and 3. reliable software for adaptive control strategy and
optimal dosage regimen calculation. The benefit of optimal drug therap
y by adaptive control using MAP Bayesian fitting has been proven, resu
lting in improved patient outcome by improved efficacy of therapy and
a reduction of adverse reactions, and in reduced costs, mainly due to
a reduction of hospitalization. Newer strategies might replace the MAP
Bayesian fitting procedure, if their advantage has been demonstrated
convincingly, and if reliable and user-friendly software is available.